256 related articles for article (PubMed ID: 7775115)
21. Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence.
Engel LS; Hill JM; Moreau JM; Green LC; Hobden JA; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):662-5. PubMed ID: 9501882
[TBL] [Abstract][Full Text] [Related]
22. Synergistic effect of immune gamma-globulin fraction on protection by antibiotic against corneal ulcers in experimental mice infected with Pseudomonas aeruginosa.
Kawaharajo K; Homma JY
Jpn J Exp Med; 1976 Jun; 46(3):155-65. PubMed ID: 822190
[TBL] [Abstract][Full Text] [Related]
23. Pseudomonas deficient in protease IV has significantly reduced corneal virulence.
Engel LS; Hobden JA; Moreau JM; Callegan MC; Hill JM; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 1997 Jul; 38(8):1535-42. PubMed ID: 9224281
[TBL] [Abstract][Full Text] [Related]
24. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
Zaidi TS; Priebe GP; Pier GB
Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
[TBL] [Abstract][Full Text] [Related]
25. In vivo activity of proteases of Pseudomonas aeruginosa in a rat model.
Döring G; Dalhoff A; Vogel O; Brunner H; Dröge U; Botzenhart K
J Infect Dis; 1984 Apr; 149(4):532-7. PubMed ID: 6427361
[TBL] [Abstract][Full Text] [Related]
26. Immunization against experimental Pseudomonas aeruginosa and Serratia marcescens keratitis. Vaccination with lipopolysaccharide endotoxins and proteases.
Kreger AS; Lyerly DM; Hazlett LD; Berk RS
Invest Ophthalmol Vis Sci; 1986 Jun; 27(6):932-9. PubMed ID: 3519522
[TBL] [Abstract][Full Text] [Related]
27. Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis.
Döring G; Obernesser HJ; Botzenhart K; Flehmig B; Høiby N; Hofmann A
J Infect Dis; 1983 Apr; 147(4):744-50. PubMed ID: 6404993
[TBL] [Abstract][Full Text] [Related]
28. Degradation of uniquely glycosylated secretory immunoglobulin a in tears from patients with Pseudomonas aeruginosa keratitis.
Lomholt JA; Kilian M
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4939-44. PubMed ID: 18757515
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic effect of immunization with OEP, protease toxoid and elastase toxoid on corneal ulcers in mice due to Pseudomonas aeruginosa infection.
Hirao Y; Homma JY
Jpn J Exp Med; 1978 Feb; 48(1):41-51. PubMed ID: 97424
[TBL] [Abstract][Full Text] [Related]
30. Role of bacterial proteases in pseudomonal and serratial keratitis.
Matsumoto K
Biol Chem; 2004 Nov; 385(11):1007-16. PubMed ID: 15576320
[TBL] [Abstract][Full Text] [Related]
31. Antibody hyporesponsiveness in resistant BALB/cJ mice intracorneally infected with Pseudomonas aeruginosa.
Berk RS; Preston M; Montgomery IN; Hazlett LD; Tse HY
Reg Immunol; 1990-1991; 3(4):186-92. PubMed ID: 2129603
[TBL] [Abstract][Full Text] [Related]
32. Characterization of arachidonic acid metabolism and the polymorphonuclear leukocyte response in mice infected intracorneally with Pseudomonas aeruginosa.
Kernacki KA; Berk RS
Invest Ophthalmol Vis Sci; 1995 Jan; 36(1):16-23. PubMed ID: 7822143
[TBL] [Abstract][Full Text] [Related]
33. Murine ocular heparanase expression before and during infection with Pseudomonas aeruginosa.
Berk RS; Dong Z; Alousi S; Kosir MA; Wang Y; Vlodavsky I
Invest Ophthalmol Vis Sci; 2004 Apr; 45(4):1182-7. PubMed ID: 15037586
[TBL] [Abstract][Full Text] [Related]
34. Membrane-type matrix metalloproteinases in mice intracorneally infected with Pseudomonas aeruginosa.
Dong Z; Ghabrial M; Katar M; Fridman R; Berk RS
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4189-94. PubMed ID: 11095614
[TBL] [Abstract][Full Text] [Related]
35. The Role of Elastase in Corneal Epithelial Barrier Dysfunction Caused by Pseudomonas aeruginosa Exoproteins.
Li Y; Wang Y; Li C; Zhao D; Hu Q; Zhou M; Du M; Li J; Wan P
Invest Ophthalmol Vis Sci; 2021 Jul; 62(9):7. PubMed ID: 34232259
[TBL] [Abstract][Full Text] [Related]
36. Plasminogen Activators and Inhibitors in the Corneas of Mice Infected with Pseudomonas aeruginosa.
Berk RS; Katar M; Dong Z; Day DE
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1561-7. PubMed ID: 11381061
[TBL] [Abstract][Full Text] [Related]
37. Pseudomonas keratitis. The role of an uncharacterized exoprotein, protease IV, in corneal virulence.
O'Callaghan RJ; Engel LS; Hobden JA; Callegan MC; Green LC; Hill JM
Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):534-43. PubMed ID: 8595953
[TBL] [Abstract][Full Text] [Related]
38. An ocular strain of Pseudomonas aeruginosa is inflammatory but not virulent in the scarified mouse model.
Cowell BA; Willcox MD; Hobden JA; Schneider RP; Tout S; Hazlett LD
Exp Eye Res; 1998 Sep; 67(3):347-56. PubMed ID: 9778416
[TBL] [Abstract][Full Text] [Related]
39. Early TIMP gene expression after corneal infection with Pseudomonas aeruginosa.
Kernacki KA; Goebel DJ; Poosch MS; Hazlett LD
Invest Ophthalmol Vis Sci; 1998 Feb; 39(2):331-5. PubMed ID: 9477990
[TBL] [Abstract][Full Text] [Related]
40. TLR4 is required for host resistance in Pseudomonas aeruginosa keratitis.
Huang X; Du W; McClellan SA; Barrett RP; Hazlett LD
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4910-6. PubMed ID: 17065506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
